Eli Lilly, Novo Nordisk Shares Dip as Pfizer Ramps Up Diabetes Drug Competition

Shares of $Eli Lilly and Co(LLY.US)$ and $Novo-Nordisk A/S(NVO.US)$ finished lower on Thursday, perhaps influenced by competitive developments and regulatory updates in the pharmaceutical sector.

Benzinga17minutes ago

FTC to Sue Pharmacy Benefit Managers Over Insulin Prices

By Liz Essley Whyte and Anna Wilde Mathews The Federal Trade Commission is preparing to sue the largest three pharmacy-benefit managers over their tactics for negotiating prices for drugs including

WSJJul 10 16:23 ET

Bernie Sanders Targets High Prices of Ozempic and Wegovy In US

Senator Bernie Sanders expressed confidence that Novo Nordisk A/S (NYSE:NVO) can be persuaded to reduce the U.S. prices of its popular weight-loss drugs, Ozempic and Wegovy, by publicly highlighting

Benzinga13:47 ET

Eli Lilly Price Target Raised to $1000.00/Share From $850.00 by Berenberg

Eli Lilly Price Target Raised to $1000.00/Share From $850.00 by

Dow Jones12:52 ET

Berenberg Maintains Buy on Eli Lilly and Co, Raises Price Target to $1000

Berenberg analyst Kerry Holford maintains Eli Lilly and Co (NYSE:LLY) with a Buy and raises the price target from $850 to $1000.

Benzinga12:42 ET

Tesla Is a 'Faith-based Stock' With Fundamentals Not Grounded in the Near-term - DataTrek

Seeking AlphaJul 11 11:59 ET